SNP rs2180341 per-allele hazard ratios (HRs) and 95% confidence intervals (CIs) among Consortium of Investigators of Modifiers of <i>BRCA1/2</i> (CIMBA) in A. <i>BRCA1</i> mutation carriers B. <i>BRCA2</i> mutation carriers.
Tomas Kirchhoff(Memorial Sloan Kettering Cancer Center), Thijs Van Dorpe, Sei Hyun Ahn(Ewha Womans University), Nichola Johnson(Institute of Cancer Research), Angela Cox, Marjanka K. Schmidt(University of Cambridge), Chia‐Ni Hsiung(Tri-Service General Hospital), Hiltrud Brauch(German Cancer Research Center), Peter Schürmann(Hannover Re (Germany)), Laura van ‘t Veer, Julian Peto(London School of Hygiene & Tropical Medicine), Clare Turnbull(Institute of Cancer Research), Thilo Dörk(Hannover Re (Germany)), Annegien Broeks, Antonis C. Antoniou(Weatherford College), Alison M. Dunning(University of Cambridge), Daehee Kang(Seoul National University), Malcolm Reed(Yorkshire Cancer Research), Celine M. Vachon(Leiden University Medical Center), Pei‐Ei Wu(Institute of Biomedical Sciences, Academia Sinica), Olivia Fletcher(Breast Cancer Care), Linde M. Braaf(The Netherlands Cancer Institute), Stig E. Bojesen(University of Copenhagen), Mia M. Gaudet(Cancer Prevention Institute of California), Børge G. Nordestgaard(Gentofte Hospital), Xianshu Wang(Kunming University of Science and Technology), Manjeet K. Humphreys(University of Cambridge), Jyh-Cherng Yu(Tri-Service General Hospital), Janet E. Olson(Cornell University), Dong‐Young Noh(Seoul National University), Melissa C. Southey(The University of Melbourne), Nazneen Rahman(Institute of Cancer Research), Keun-Young Yoo, Chenyang Shen, Ute Hamann(German Cancer Research Center), Barbara Burwinkel(German Cancer Research Center), Anthony Renwick(Institute of Cancer Research), Lesley McGuffog(University of Cambridge), John L. Hopper(The University of Melbourne), Sheila Seal(Institute of Cancer Research), Ian W. Brock(University of Sheffield), Johann H. Karstens(Medizinische Hochschule Hannover), Fergus J. Couch(Mayo Clinic), Graeme Elliott(University of Sheffield), Lorna J. Gibson(London School of Hygiene & Tropical Medicine), Henrik Flyger(Herlev Hospital), Peter Hillemanns(Medizinische Hochschule Hannover), Yon-Dschun Ko, Fleur Hammet(Monash Health)
Cited by 0
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k